Arkolith/Insider Trading/ANIK/Form 4

Blanchard Cheryl R

President, CEO, Director, DirectorAnika Therapeutics, Inc. (ANIK) · full profile →Form 4 · filed Mar 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)6K$16.62$98K167K
Mar 10, 2025Option exercise(M)20K—$0173K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2025Option exercise(M)20K—$020K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001171843-25-001404) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML